使用氨甲环酸的流程改进项目在全髋和全膝关节置换术后减少失血和输血方面具有成本效益
该流程改进项目在全髋和全膝关节置换术中标准化给予氨甲环酸后,回顾性比较项目实施前12个月(A组336例手术)与实施后12个月(B组436例手术)的数据,发现氨甲环酸使用率从3.57%升至86.01%,围手术期血红蛋白下降、输血患者比例和人均输血单位数均减少,并节约了人均和项目年度成本,未观察到不良反应增加。
要点
- 项目实施后氨甲环酸使用率从3.57%升至86.01%,与围手术期血红蛋白下降减少20.2%、输血患者减少45%、人均输血单位数减少61.9%相关。
- 人均节约成本128美元,项目年度总节约55,884美元,其中初次全髋关节置换亚组贡献最大。
- 未观察到不良反应增加。
核心结论
- 标准化给予氨甲环酸是择期全髋或全膝关节置换患者有效且经济上有利的减少失血策略。
- 尽管全膝关节置换后氨甲环酸减少输血可能更多,但减少输血的经济和临床影响在全髋关节置换患者中更为显著。
研究设计与样本
- 流程改进项目,回顾性比较项目实施前12个月连续数据(A组,336例手术)与项目实施后12个月连续数据(B组,436例手术)。
主要发现
- 氨甲环酸使用率随项目实施增加(A组3.57% vs B组86.01%)。
- 与项目实施相关,围手术期血红蛋白下降减少20.2%、输血患者减少45%、人均输血单位数减少61.9%。
- 人均节约成本128美元,项目年度总节约55,884美元,初次全髋关节置换亚组贡献最大。
- 未观察到不良反应增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) has been associated with decreased blood loss and transfusion after total hip arthroplasty (THA) and total knee arthroplasty (TKA). The purpose of this study was to examine both transfusion utilization and the economic impact of a Process Improvement Project implementing TXA for THA and TKA. METHODS: After standardization of TXA administration in THA and TKA patients, retrospective data were compared from 12 consecutive months before (group A, n = 336 procedures) and after (group B, n = 436 procedures) project initiation. RESULTS: TXA administration increased with project implementation (group A = 3.57%, group B = 86.01%) and was associated with reductions in perioperative hemoglobin decrement (20.2%), patients transfused (45%), and number of units transfused per patient (61.9%). Cost savings were notable per patient ($128) and annually program wide ($55,884) with the primary THA subgroup contributing the most to the savings. No increase in adverse effects was observed. CONCLUSION: Standardized administration of TXA is an effective and economically favorable blood-reduction strategy for patients undergoing elective THA or TKA. Although reduction in transfusions with TXA may be greater after TKA, the economic and clinical impact of transfusion reduction is more substantial in THA patients.
引用
- Demos HA, Lin ZX, Barfield WR, et al. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2017. PMID: 28343823. doi:10.1016/j.arth.2017.02.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。